The pharmaceutical giant is a standout performer within the health-care sector, and the stock could be poised for a big jump.
With the Federal Open Market Committee's first meeting of the year this afternoon — followed by earnings from three of the "Magnificent Seven" — there's no shortage of near-term catalysts today. This ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results